Syngen Biotech Co.,Ltd. (TPEX: 8279)

Market Cap	3.36B
Revenue (ttm)	2.00B
Net Income (ttm)	238.77M
Shares Out	27.10M
EPS (ttm)	8.81
PE Ratio	14.07
Forward PE	n/a
Dividend	5.00 (4.03%)
Ex-Dividend Date	Jun 27, 2024

Volume	23,315
Open	123.50
Previous Close	126.00
Day's Range	123.50 - 127.00
52-Week Range	123.50 - 177.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 7, 2025

About Syngen Biotech Co.,Ltd.

Syngen Biotech Co.,Ltd. engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicine. It also offers contract manufacturing; science-based and bio active pharmaceutical ingredients; and private labelling. In addition, the company provides organic food OEM/ODM, explosion proof extraction, brand agency, and wholesale distribution services. The company was founded in 1988 and is based in Tainan City, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1988
• Employees: 247
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 8279

Financial Performance

In 2023, Syngen Biotech Co.,Ltd.'s revenue was 1.84 billion, a decrease of -4.84% compared to the previous year's 1.93 billion. Earnings were 274.83 million, a decrease of -14.45%.